PERSPECTA

News from every angle

Back to headlines

High-Stakes Bets on Experimental Cancer Therapies Begin to Pay Off

Former Moderna executive Tal Zaks and a fellow scientist describe how their early, principle-driven investments in unconventional cancer treatments are finally yielding significant breakthroughs ahead of 2026.

5 Sept, 09:00 — 5 Sept, 09:00
PostShare